PARI’s LC Sprint & TREK S Featured in ‘ER’ Final Episode on NBC Thursday
“We are very pleased that NBC would use the final episode of ‘ER’ to once again highlight respiratory conditions and therapies. So many Americans suffer from a wide variety of respiratory illnesses and degenerative conditions that it makes sense that writers would use real-life examples and industry-leading nebulizers in their story lines,” said
The LC Sprint is the next generation nebulizer that has been used to deliver aerosol therapies for asthma, COPD, and cystic fibrosis. Combined with PARI’s TREK S, the LC Sprint delivers medication treatments averaging between 5 to 6 minutes.
The PARI LC Sprint features breath-enhancement, where a patient’s unique breathing pattern controls and optimizes medication delivery to the lungs by means of two valves on the nebulizer. PARI’s TREK S is a compact, portable compressor that is powered by a lithium ion battery or used with an AC adaptor.
About PARI Respiratory Equipment, Inc.
PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI’s worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.
Maker of the world’s leading breath-enhanced reusable nebulizer, the PARI LC PLUS, and the new PARI LC Sprint nebulizer line, PARI also manufactures the award winning PARI TREK S compact compressor, Bubbles the Fish II aerosol mask, and durable PARI PRONEB Ultra II. PARI’s Vortex anti-static valved holding chamber improves the aerosol deposition of metered dose inhalers (MDIs). PARI’s North American headquarters is in
Additional information is available by contacting
SOURCE PARI Respiratory Equipment, Inc.